Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012 (2012), Article ID 489830, 12 pages
http://dx.doi.org/10.1100/2012/489830
Review Article

Genetics and Epigenetics of Parkinson's Disease

1Faculty of Medicine, University of Pisa, 56126 Pisa, Italy
2Genetics and Epigenetics of Complex Disease Program, Department of Neuroscience (DAI Neuroscience), Pisa University Hospital, Via S. Giuseppe 22, 56126 Pisa, Italy

Received 15 October 2011; Accepted 21 December 2011

Academic Editors: H. Cui and M. Hiltunen

Copyright © 2012 Fabio Coppedè. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [46 citations]

The following is the list of published articles that have cited the current article.

  • K. Gapp, B.T. Woldemichael, J. Bohacek, and I.M. Mansuy, “Epigenetic regulation in neurodevelopment and neurodegenerative diseases,” Neuroscience, 2012. View at Publisher · View at Google Scholar
  • Marina Spanos, Julie Gras-Najjar, Jeremy M. Letchworth, Audrey L. Sanford, J. Vincent Toups, and Leslie A. Sombers, “Quantitation of Hydrogen Peroxide Fluctuations and Their Modulation of Dopamine Dynamics in the Rat Dorsal Striatum Using Fast-Scan Cyclic Voltammetry,” ACS Chemical Neuroscience, vol. 4, no. 5, pp. 782–789, 2013. View at Publisher · View at Google Scholar
  • Jane S. Paulsen, Martha Nance, Ji-In Kim, Noelle E. Carlozzi, Peter K. Panegyres, Cheryl Erwin, Anita Goh, Elizabeth McCusker, and Janet K. Williams, “A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases,” Progress in Neurobiology, vol. 110, pp. 2–28, 2013. View at Publisher · View at Google Scholar
  • Jj Chen Jia-Jun, Mx Tian Ming-Xiu, Xa Li Xing-An, and Ls Hu Lin-Sen, “An Analysis of Protein Bioinformatics Datasets Related to Lewy Bodies of Parkinson's Disease,” Progress in Biochemistry and Biophysics, vol. 40, no. 11, pp. 1100–1106, 2013. View at Publisher · View at Google Scholar
  • Paul R. Heath, Oliver Bandmann, Janine Kirby, and Pamela J. Shaw, “Neuronal dark matter: the emerging role of microRNAs in neurodegeneration,” Frontiers in Cellular Neuroscience, vol. 7, 2013. View at Publisher · View at Google Scholar
  • Radu Constantinescu, and Stefania Mondello, “Cerebrospinal fluid biomarker candidates for Parkinsonian disorders,” Frontiers in Neurology, vol. 3, 2013. View at Publisher · View at Google Scholar
  • G. Natale, E. Pompili, F. Biagioni, S. Paparelli, P. Lenzi, and F. Fornai, “Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases,” European Journal of Histochemistry, vol. 57, no. 1, pp. 31–35, 2013. View at Publisher · View at Google Scholar
  • Fabio Coppedè, “The potential of epigenetic therapies in neurodegenerative diseases,” Frontiers in Genetics, vol. 5, 2014. View at Publisher · View at Google Scholar
  • Kazunari Sekiyama, Yoshiki Takamatsu, Masaaki Waragai, and Makoto Hashimoto, “Role of genomics in tranaslational research for parkinson’s disease,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Margherita Grasso, Paola Piscopo, Annamaria Confaloni, and Michela A. Denti, “Circulating miRNAs as Biomarkers for Neurodegenerative Disorders,” Molecules, vol. 19, no. 5, pp. 6891–6910, 2014. View at Publisher · View at Google Scholar
  • Nandhini Kanagaraj, He Beiping, S. Thameem Dheen, and Samuel Sam Wah Tay, “Downregulation of miR-124 in MPTP-treated mouse model of Parkinson’s disease and MPP iodide treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins,” Neuroscience, 2014. View at Publisher · View at Google Scholar
  • Ti-Fei Yuan, Jiang Li, and Chun-Lei Shan, “The Epigenetics Changes in Parkinson's Disease: a Novel Therapeutic Target,” CNS Neuroscience & Therapeutics, vol. 20, no. 4, pp. 299–300, 2014. View at Publisher · View at Google Scholar
  • Maria Teresa Baltazar, Ricardo Jorge Dinis-Oliveira, Maria de Lourdes Bastos, Aristidis M. Tsatsakis, José Alberto Duarte, and Félix Carvalho, “Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach,” Toxicology Letters, 2014. View at Publisher · View at Google Scholar
  • Wei Xu, Lan Tan, and Jin-Tai Yu, “The link between the SNCA gene and parkinsonism,” Neurobiology of Aging, 2014. View at Publisher · View at Google Scholar
  • M Remely, L Lovrecic, A L de la Garza, L Migliore, B Peterlin, F I Milagro, A J Martinez, and A G Haslberger, “Therapeutic perspectives of epigenetically active nutrients,” British Journal of Pharmacology, 2014. View at Publisher · View at Google Scholar
  • Ya Feng, Joseph Jankovic, and Yun-Cheng Wu, “Epigenetic mechanisms in Parkinson’s disease,” Journal of the Neurological Sciences, 2014. View at Publisher · View at Google Scholar
  • Fabio Coppedè, and Lucia Migliore, “DNA damage in neurodegenerative diseases,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2014. View at Publisher · View at Google Scholar
  • Xinling Yang, “Analysis of Thr12Met and Ala1144Thr Mutations of the ATP13A2 Gene in Parkinson’s Disease Patients in Xinjiang Uygur and Han Ethnic Groups,” Medical Science Monitor, vol. 20, pp. 2177–2182, 2014. View at Publisher · View at Google Scholar
  • Judith Eschbach, and Karin M. Danzer, “a-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models,” Neurodegenerative Diseases, vol. 14, no. 1, pp. 1–17, 2014. View at Publisher · View at Google Scholar
  • Xinglong Yang, and Yanming Xu, “ Mutations in the ATP13A2 Gene and Parkinsonism: A Preliminary Review ,” BioMed Research International, vol. 2014, pp. 1–9, 2014. View at Publisher · View at Google Scholar
  • Jacob Peedicayil, “Epigenetic drugs in cognitive disorders,” Current Pharmaceutical Design, vol. 20, no. 11, pp. 1840–1846, 2014. View at Publisher · View at Google Scholar
  • Smriti Gupta, Savita Verma, Shrikant Mantri, Nancy E. Berman, and Rajat Sandhir, “Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative Disorders,” Drug Development Research, 2015. View at Publisher · View at Google Scholar
  • André V. Carreiro, Alexandre Mendonça, Mamede de Carvalho, and Sara C. Madeira, “Integrative biomarker discovery in neurodegenerative diseases,” Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2015. View at Publisher · View at Google Scholar
  • Chong-Dong Jian, Jian-Min Huang, Lan-Qing Meng, Xue-Bin Li, Rui-Ya Huang, Sheng-Liang Shi, Yuan Wu, Chao Qin, Jin Chen, Yan-Mei Zhang, Shuang Wang, Yin-Ling Feng, and Sheng-Nian Zhou, “ SNCA rs3822086 C>T Polymorphism Increases the Susceptibility to Parkinson's Disease in a Chinese Han Population ,” Genetic Testing and Molecular Biomarkers, pp. 150723112651005, 2015. View at Publisher · View at Google Scholar
  • Gabriela S. Longo, Marcela A. S. Pinhel, Michele L. Gregorio, Bruno A. P. Oliveira, Driele C. G. Quinhoneiro, Waldir A. Tognola, Fabio N. Oliveira, Sabrina M. Cezario, Caroline L. Sado, Marcelo A. Nakazone, Maria C. J. Calastri, and Doroteia R. S. Souza, “Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson's disease patients,” Arquivos De Neuro-Psiquiatria, vol. 73, no. 6, pp. 506–509, 2015. View at Publisher · View at Google Scholar
  • Roy Lardenoije, Artemis Iatrou, Gunter Kenis, Konstantinos Kompotis, Harry W.M. Steinbusch, Diego Mastroeni, Paul Coleman, Cynthia A. Lemere, Patrick R. Hof, Daniel L.A. van den Hove, and Bart P.F. Rutten, “The Epigenetics of Aging and Neurodegeneration,” Progress in Neurobiology, 2015. View at Publisher · View at Google Scholar
  • Jorge Landgrave-Gómez, Octavio Mercado-Gómez, and Rosalinda Guevara-Guzmán, “Epigenetic mechanisms in neurological and neurodegenerative diseases,” Frontiers in Cellular Neuroscience, vol. 9, 2015. View at Publisher · View at Google Scholar
  • Lior Greenbaum, and Bernard Lerer, “Pharmacogenetics of Antipsychotic-Induced Movement Disorders as a Resource for Better Understanding Parkinson’s Disease Modifier Genes,” Frontiers in Neurology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Zhong-Kui Xiong, Juan Lang, Gang Xu, Hai-Yu Li, Yun Zhang, Lei Wang, Yao Su, and Ai-Jing Sun, “Excessive levels of nitric oxide in rat model of Parkinson's disease induced by rotenone,” Experimental And Therapeutic Medicine, vol. 9, no. 2, pp. 553–558, 2015. View at Publisher · View at Google Scholar
  • Rita Török, Dénes Zádori, Nóra Török, Éva Csility, László Vécsei, and Péter Klivényi, “An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease,” Neuroscience Letters, 2015. View at Publisher · View at Google Scholar
  • Afroza Khanam Irin, Alpha Tom Kodamullil, Michaela Gündel, and Martin Hofmann-Apitius, “Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis,” Journal of Immunology Research, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • Maria Chiara Pelleri, Fabrizio Pizzetti, Elisa Mariani, Flavia Frabetti, Andrea Tarozzi, and Raffaella Casadei, “Meta-analysis of Parkinson's disease transcriptome data using TRAM software: Whole substantia nigra tissue and single dopamine neuron differential gene expression,” PLoS ONE, vol. 11, no. 9, 2016. View at Publisher · View at Google Scholar
  • Callie E. Todt, Denise C. Bailey, Aireal S. Pressley, Sarah E. Orfield, Rachel D. Denney, Isaac B. Snapp, Rekek Negga, Andrew C. Bailey, Kara M. Montgomery, Wendy L. Traynor, and Vanessa A. Fitsanakis, “Acute Exposure to a Mn/Zn Ethylene-bis-Dithiocarbamate Fungicide Leads to Mitochondrial Dysfunction and Increased Reactive Oxygen Species Production in Caenorhabditis elegans,” NeuroToxicology, 2016. View at Publisher · View at Google Scholar
  • Shashikanta Tarai, Arindam Bit, Helton José dos Reis, András Palotás, Albert Rizvanov, and Akalabya Bissoyi, “Stratifying Heterogeneous Dimension of Neurodegenerative Diseases: Intervention for Stipulating Epigenetic Factors to Combat Oxidative Stress in Human Brain,” BioNanoScience, 2016. View at Publisher · View at Google Scholar
  • Mako Ogino, Mayuko Ichimura, Noriko Nakano, Akari Minami, Yasuko Kitagishi, and Satoru Matsuda, “Roles of PTEN with DNA Repair in Parkinson’s Disease,” International Journal of Molecular Sciences, vol. 17, no. 6, pp. 954, 2016. View at Publisher · View at Google Scholar
  • Marcia Cristina Teixeira dos Santos, Rosie Bell, and Andre Nogueira da Costa, “Recent developments in circulating biomarkers in Parkinson’s disease: the potential use of miRNAs in a clinical setting,” Bioanalysis, vol. 8, no. 23, pp. 2497–2518, 2016. View at Publisher · View at Google Scholar
  • Diana F. Lázaro, Mariana Castro Dias, Anita Carija, Susanna Navarro, Carolina Silva Madaleno, Sandra Tenreiro, Salvador Ventura, and Tiago F. Outeiro, “The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation,” Acta Neuropathologica Communications, vol. 4, no. 1, 2016. View at Publisher · View at Google Scholar
  • Maciej Grzybek, Aleksandra Golonko, Marta Walczak, and Pawel Lisowski, “Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling,” Neurobiology of Disease, 2016. View at Publisher · View at Google Scholar
  • Anelya Kh. Alieva, Elena V. Filatova, Anna A. Kolacheva, Margarita M. Rudenok, Petr A. Slominsky, Mikhail V. Ugrumov, and Maria I. Shadrina, “Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson’s Disease,” Molecular Neurobiology, 2016. View at Publisher · View at Google Scholar
  • Fabio Coppedè, Andrea Stoccoro, Lorena Mosca, Roberta Gallo, Claudia Tarlarini, Christian Lunetta, Alessandro Marocchi, Lucia Migliore, and Silvana Penco, “ Increase in DNA methylation in patients with amyotrophic lateral sclerosis carriers of not fully penetrant SOD1 mutations ,” Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, pp. 1–9, 2017. View at Publisher · View at Google Scholar
  • Jian Yang, Zhaofei Yang, Xuan Wang, Min Sun, Yong Wang, and Xiaomin Wang, “CpG demethylation in the neurotoxicity of 1-methyl-4-phenylpyridinium might mediate transcriptional up-regulation of α-synuclein in SH-SY5Y cells,” Neuroscience Letters, 2017. View at Publisher · View at Google Scholar
  • Ernesto Miranda-Morales, Karin Meier, Ada Sandoval-Carrillo, José Salas-Pacheco, Paola Vázquez-Cárdenas, and Oscar Arias-Carrión, “Implications of DNA Methylation in Parkinson’s Disease,” Frontiers in Molecular Neuroscience, vol. 10, 2017. View at Publisher · View at Google Scholar
  • Ramón Cacabelos, “Parkinson’s Disease: From Pathogenesis to Pharmacogenomics,” International Journal of Molecular Sciences, vol. 18, no. 3, pp. 551, 2017. View at Publisher · View at Google Scholar
  • Bryan Andrew Killinger, and Viviane Labrie, “Vertebrate food products as a potential source of prion-like α-synuclein,” npj Parkinson's Disease, vol. 3, no. 1, 2017. View at Publisher · View at Google Scholar
  • Claudia Consales, Claudia Cirotti, Giuseppe Filomeni, Martina Panatta, Alessio Butera, Caterina Merla, Vanni Lopresto, Rosanna Pinto, Carmela Marino, and Barbara Benassi, “Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells,” Molecular Neurobiology, 2017. View at Publisher · View at Google Scholar
  • Ahmed Bouhouche, Houyam Tibar, Rafiqua Ben El Haj, Khalil El Bayad, Rachid Razine, Sanaa Tazrout, Asmae Skalli, Naima Bouslam, Loubna Elouardi, Ali Benomar, Mohammed Yahyaoui, and Wafa Regragui, “ LRRK2 G2019S Mutation: Prevalence and Clinical Features in Moroccans with Parkinson’s Disease ,” Parkinson's Disease, vol. 2017, pp. 1–7, 2017. View at Publisher · View at Google Scholar